These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 22529899)
1. Biodegradable thermosensitive hydrogel for SAHA and DDP delivery: therapeutic effects on oral squamous cell carcinoma xenografts. Li J; Gong C; Feng X; Zhou X; Xu X; Xie L; Wang R; Zhang D; Wang H; Deng P; Zhou M; Ji N; Zhou Y; Wang Y; Wang Z; Liao G; Geng N; Chu L; Qian Z; Wang Z; Chen Q PLoS One; 2012; 7(4):e33860. PubMed ID: 22529899 [TBL] [Abstract][Full Text] [Related]
2. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel. Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675 [TBL] [Abstract][Full Text] [Related]
3. Enhanced anticancer efficacy of histone deacetyl inhibitor, suberoylanilide hydroxamic acid, in combination with a phosphodiesterase inhibitor, pentoxifylline, in human cancer cell lines and in-vivo tumor xenografts. Nidhyanandan S; Thippeswamy BS; Chandrasekhar KB; Reddy ND; Kulkarni NM; Karthikeyan K; Khan FR; Raghul J; Vijaykanth G; Narayanan S Anticancer Drugs; 2017 Oct; 28(9):1002-1017. PubMed ID: 28727579 [TBL] [Abstract][Full Text] [Related]
4. Prevention of corneal neovascularization by subconjunctival injection of avastin® loaded thermosensitive hydrogels in rabbit model. Xu X; Yu J; Shi H; Zhang J; Li X Int J Pharm; 2018 Dec; 552(1-2):164-170. PubMed ID: 30217769 [TBL] [Abstract][Full Text] [Related]
5. Thermosensitive hydrogel used in dual drug delivery system with paclitaxel-loaded micelles for in situ treatment of lung cancer. Wu Z; Zou X; Yang L; Lin S; Fan J; Yang B; Sun X; Wan Q; Chen Y; Fu S Colloids Surf B Biointerfaces; 2014 Oct; 122():90-98. PubMed ID: 25033428 [TBL] [Abstract][Full Text] [Related]
6. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice. Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267 [TBL] [Abstract][Full Text] [Related]
7. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice. Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373 [TBL] [Abstract][Full Text] [Related]
8. Thermosensitive PEG-PCL-PEG (PECE) hydrogel as an in situ gelling system for ocular drug delivery of diclofenac sodium. Luo Z; Jin L; Xu L; Zhang ZL; Yu J; Shi S; Li X; Chen H Drug Deliv; 2016; 23(1):63-8. PubMed ID: 24758189 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of SAHA, a novel histone deacetylase inhibitor, against murine B cell lymphoma A20 cells in vitro and in vivo. Yang B; Yu D; Liu J; Yang K; Wu G; Liu H Tumour Biol; 2015 Jul; 36(7):5051-61. PubMed ID: 25649979 [TBL] [Abstract][Full Text] [Related]
10. Local delivery of gambogic acid to improve anti-tumor immunity against oral squamous cell carcinoma. Chen X; Chen DR; Liu H; Yang L; Zhang Y; Bu LL; Sun ZJ; Cai L J Control Release; 2022 Nov; 351():381-393. PubMed ID: 36096364 [TBL] [Abstract][Full Text] [Related]
11. Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer. Konstantinopoulos PA; Wilson AJ; Saskowski J; Wass E; Khabele D Gynecol Oncol; 2014 Jun; 133(3):599-606. PubMed ID: 24631446 [TBL] [Abstract][Full Text] [Related]
12. Pendant HDAC inhibitor SAHA derivatised polymer as a novel prodrug micellar carrier for anticancer drugs. Xu J; Sun J; Wang P; Ma X; Li S J Drug Target; 2018; 26(5-6):448-457. PubMed ID: 29251528 [TBL] [Abstract][Full Text] [Related]
13. Growth-suppressive effect of suberoylanilide hydroxamic acid (SAHA) on human oral cancer cells. Jang B; Shin JA; Kim YS; Kim JY; Yi HK; Park IS; Cho NP; Cho SD Cell Oncol (Dordr); 2016 Feb; 39(1):79-87. PubMed ID: 26582320 [TBL] [Abstract][Full Text] [Related]
14. In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model. Thiemann M; Oertel S; Ehemann V; Weichert W; Stenzinger A; Bischof M; Weber KJ; Perez RL; Haberkorn U; Kulozik AE; Debus J; Huber PE; Battmann C Radiat Oncol; 2012 Mar; 7():52. PubMed ID: 22458853 [TBL] [Abstract][Full Text] [Related]
15. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo. Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428 [TBL] [Abstract][Full Text] [Related]
16. Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier. Ma W; Sun J; Xu J; Luo Z; Diao D; Zhang Z; Oberly PJ; Minnigh MB; Xie W; Poloyac SM; Huang Y; Li S Theranostics; 2020; 10(6):2463-2478. PubMed ID: 32194813 [TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous cell carcinoma cell lines in vitro and in vivo. Nagumo T; Takaoka S; Yoshiba S; Ohashi M; Shirota T; Hatori M; Isobe T; Tachikawa T; Shintani S Oral Oncol; 2009 Sep; 45(9):766-70. PubMed ID: 19157955 [TBL] [Abstract][Full Text] [Related]
18. Synergistic suppressive effect of PARP-1 inhibitor PJ34 and HDAC inhibitor SAHA on proliferation of liver cancer cells. Liang BY; Xiong M; Ji GB; Zhang EL; Zhang ZY; Dong KS; Chen XP; Huang ZY J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):535-540. PubMed ID: 26223923 [TBL] [Abstract][Full Text] [Related]
19. Acute toxicity evaluation of biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PEG-PCL-PEG hydrogel. Gong CY; Wu QJ; Dong PW; Shi S; Fu SZ; Guo G; Hu HZ; Zhao X; Wei YQ; Qian ZY J Biomed Mater Res B Appl Biomater; 2009 Oct; 91(1):26-36. PubMed ID: 19365823 [TBL] [Abstract][Full Text] [Related]
20. Thermosensitive PEG-PCL-PEG hydrogel controlled drug delivery system: sol-gel-sol transition and in vitro drug release study. Gong CY; Dong PW; Shi S; Fu SZ; Yang JL; Guo G; Zhao X; Wei YQ; Qian ZY J Pharm Sci; 2009 Oct; 98(10):3707-17. PubMed ID: 19189419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]